Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Cemdisiran Linked With Fewer Hospitalizations in Myasthenia Gravis Study

(MedPage Today) -- Cemdisiran, an investigational small interfering RNA (siRNA) therapeutic targeting complement component 5 (C5), led to fewer hospitalized myasthenia gravis patients compared with placebo, a prespecified exploratory analysis of...

Cemdisiran Linked With Fewer Hospitalizations in Myasthenia Gravis Study

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Thursday 1 October →